Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideTMOThermo Fisher Scientific
FinDog View：Bullish
UNHUnitedHealth Group
FinDog View：Neutral
| Metric | TMO | UNH |
|---|
| Close | 648.43 | 375.26 |
| Market Cap | $240B | $337B |
| 1M | +10.75% | −5.15% |
| P/E (TTM) | 34.4 | 23.9 |
| Forward P/E | 21.8 | 19.7 |
| P/E 5-Yr Percentile | 65 | 53 |
| P/S | 5.2 | 0.8 |
| P/B | 4.6 | 3.2 |
| Dividend Yield | 0.29% | 1.37% |
| Latest Quarter Revenue | $12.0B | $112B |
| Revenue YoY | +10.5% | +0.4% |
| Gross Margin | — | 88.1% |
| Latest Quarter EPS | 4.68 | 6.04 |
| Avg Post-Earnings Move | ±1.2% | ±3.1% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.36% | 2.89% |
| 90-Day Net Insider Buying | −$38.9M | −$0.66M |
TMO · Revenue, Last 8 Quarters ($B)
UNH · Revenue, Last 8 Quarters ($B)
